However, a high glycolysis-related gene signature score was significantly correlated with several characteristics: age (OR = 0.85, 95% CI 0.73–0.99, P = 0.03, Figure S5A), tumor size (OR = 1.73, 95% CI 1.26–2.37, P < 0.001, Figure S5B), tumor differentiation (OR = 1.47, 95% CI 1.06–2.05, P = 0.02, Figure S5C), AFP (OR = 1.81, 95% CI 1.53–2.15, P < 0.001, Figure S5D), vascular invasion (OR = 2.37, 95% CI 1.95–2.88, P < 0.001, Figure S5E), clinical stage (OR = 3.67, 95% CI 1.25–10.76, P = 0.02, Figure S5F), and tumor embolus (OR = 3.49, 95% CI 1.98–6.15, P < 0.001, Figure S5G). This evidence concerns the gene AFP and neoplasm.